Anzeige
Mehr »
Mittwoch, 17.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1C72G | ISIN: BMG8162K1137 | Ticker-Symbol: TEL1
Frankfurt
16.09.25 | 09:06
0,174 Euro
-6,95 % -0,013
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD Chart 1 Jahr
5-Tage-Chart
SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,1670,19016.09.
0,1710,18716.09.

Aktuelle News zur SIHUAN PHARMACEUTICAL HOLDINGS GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoSIHUAN PHARM (00460): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDER1
MoSIHUAN PHARM (00460): NOTIFICATION LETTER AND CHANGE REQUEST FORM TO REGISTERED SHAREHOLDER1
MoSIHUAN PHARM (00460): INTERIM REPORT 2025-
09.09.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT-GLP-1R/GCGR DUAL TARGET INNOVATIVE DRUG P052 INJECTION INDEPENDENTLY DEVELOPED BY HUISHENG BIOPHARMACEUTICAL ...1
04.09.SIHUAN PHARM (00460): UPDATE ON THE PROPOSED SPIN-OFF AND SEPARATE LISTING OF XUANZHU BIOPHARM ON THE MAIN BOARD OF THE STOCK EXCHANGE OF HONG KONG LIMITED ...-
03.09.HSI Closes Midday at 25,395, Down 101 pts; HSTI Closes Midday at 5,697, Down 31 pts; ZHONGSHENG HLDG Up over 4%; CSPC PHARMA, CHOW TAI FOOK, MEDBOT-B, PA GOODDOCTOR, SIHUAN PHARM Hit New Highs7
SIHUAN PHARMACEUTICAL HOLDINGS GROUP Aktie jetzt für 0€ handeln
02.09.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT SHARE REPURCHASE3
02.09.SIHUAN PHARM (00460): NEXT DAY DISCLOSURE RETURN-
01.09.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT-SIHUAN PHARMACEUTICAL AND DPROTEIN JOINTLY ESTABLISHED AI R&D COMPANY TO EXPLORE DEVELOPMENT OF AI-DRIVEN ...1
29.08.SIHUAN PHARM (00460): NOMINATION COMMITTEE TERMS OF REFERENCE ADOPTED BY THE BOARD ON 8 OCTOBER 2010 AND AMENDED BY THE BOARD ON 19 MARCH 2012, 18 MARCH ...2
29.08.SIHUAN PHARM (00460): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION1
29.08.SIHUAN PHARM (00460): CHANGE IN COMPOSITION OF THE NOMINATION COMMITTEE1
29.08.SIHUAN PHARM (00460): INTERIM CASH DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 20253
29.08.SIHUAN PHARM (00460): ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 20253
22.08.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT-THE INNOVATIVE DRUG DIROZALKIB TABLETS INDEPENDENTLY DEVELOPED BY XUANZHU BIOPHARM OBTAINED DRUG REGISTRATION ...2
19.08.SIHUAN PHARM (00460): NOTICE OF BOARD MEETING-
15.08.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT - THE NDA OF SEMAGLUTIDE INJECTION DEVELOPED BY HUISHENG BIOPHARMACEUTICAL ACCEPTED BY THE NMPA-
01.08.SIHUAN PHARM (00460): POSITIVE PROFIT ALERT-
30.07.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT-COMPLETION OF FIRST PATIENT ENROLLMENT IN PHASE III CLINICAL TRIAL FOR NEW INDICATION OF INNOVATIVE DRUG ...1
07.07.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO THE SHARE AWARD SCHEME-
Weiter >>
46 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1